✦ LIBER ✦

From the Editor: What are the important questions for clinical trials?

✍ Scribed by W. Virgil Brown

Book ID: 118460876
Publisher: Elsevier
Year: 2012
Tongue: English
Weight: 74 KB
Volume: 6
Category: Article
ISSN: 1933-2874
DOI: 10.1016/j.jacl.2012.06.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Severe asthma in adults: What are the im

Severe asthma in adults: What are the important questions?

✍ Chanez, Pascal; Wenzel, Sally E.; Anderson, Gary P.; Anto, Josep M.; Bel, Elisab 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 202 KB

What are genes “for” or where are traits

What are genes “for” or where are traits “from”? What is the question?

✍ Anne V. Buchanan; Samuel Sholtis; Joan Richtsmeier; Kenneth M. Weiss 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 1 views

Interstitial lung disease in connective

Interstitial lung disease in connective tissue diseases: What are the important questions?

✍ RYU, JAY H. ;BONGARTZ, TIM ;MATTESON, ERIC L. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 1 views

Diabetic nephropathy and antihypertensiv

Diabetic nephropathy and antihypertensive treatment: what are the lessons from clinical trials?

✍ Anastasios N Lasaridis; Panteleimon A Sarafidis 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 131 KB

What are the clinical trial priorities o

What are the clinical trial priorities of the future?

✍ Stan B. Kaye 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 822 KB

Screening for ovarian cancer: What are t

Screening for ovarian cancer: What are the optimal surrogate endpoints for clinical trials?

✍ Beth Y. Karlan 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 634 KB

The inability to identify relevant markers for presymptomatic screening in early stage or "preinvasive" ovarian cancer has plagued investigators and clinicians facing the problems of early detection. The characteristic late stage of disease at initial presentation has hindered our understanding of t